Vascular & Stroke

Vessel Wall MRI: Read the Wall, Not the Lumen

Fellowship-level neuroradiology teaching by E. Brooke Schrickel, MD. Open this topic in the interactive reading room →

Watch · concise explainerVisual summary

Core clinical idea

Luminal imaging shows the stenosis but not why it's there, and three vasculopathies can give the identical narrowed lumen. Vessel wall MRI reads the wall to tell them apart and spare invasive workup. In Part 1 the job is atherosclerosis: find the plaque and grade its vulnerability — and the signature is eccentric.

Bottom line

Vessel wall MRI reads the wall the lumen can't — for atherosclerosis, the lesion is eccentric, and you grade vulnerability, not just stenosis.

Core workstation questions

Is the blood truly suppressed, or am I reading flow artifact as wall signal?
Is the lesion eccentric (atherosclerosis) — and does it carry a lipid/necrotic core, a fibrous cap, or intraplaque hemorrhage?
Is enhancement focal and eccentric (consistent with a culprit plaque)?
Luminal imaging looks normal but symptoms recur — is there an outward-remodeled plaque the lumen is hiding?
Of several stenoses, which co-localizes with the symptomatic territory?
Is the wall enhancement circumferential and smooth (vasculitis) or eccentric (atherosclerosis)?
Does enhancement extend beyond the wall into perivascular tissue (favors vasculitis)?
Is the wall quiet/non-enhancing under multifocal stenosis in a young woman post-trigger (favors RCVS) — and will short-interval follow-up show reversibility?

What changes reporting / management

Protocol high-resolution wall imaging (3D black-blood variable-flip-angle for any-plane reformats; T1 pre/post + T2) and confirm intraluminal blood suppression before trusting wall signal.
Characterize plaque beyond stenosis: eccentric location, juxtaluminal T2-hyperintense fibrous cap, T2-hypointense lipid/necrotic core, intraplaque hemorrhage, remodeling direction, and enhancement.
Name the culprit lesion as the eccentric, focally enhancing, hemorrhage-bearing plaque that co-localizes with the symptomatic territory; expect enhancement to fade and lumen to reopen on optimal medical therapy.
When luminal imaging is normal but symptoms recur, go to vessel wall imaging before calling the study negative (outward remodeling).
Vasculitis: intense smooth circumferential ('tram-track') wall thickening/enhancement with perivascular extension, any caliber; favors inflammatory disease -> steroids/immunosuppression; use serial enhancement to track therapy and to target the most inflamed segment for biopsy.
RCVS: smooth, minimal-to-no wall thickening and minimal-to-no enhancement in a young/middle-aged woman with thunderclap headache post-trigger; recommend short-interval luminal follow-up to confirm reversibility before any immunosuppression.
Moyamoya: report terminal-ICA steno-occlusion with collaterals and use the wall to sort primary (little enhancement) vs. atherosclerotic (eccentric plaque) vs. inflammatory (vasculitic enhancement) drivers, since treatment differs (bypass vs. atherosclerosis management vs. immunosuppression).
Use atherosclerosis = eccentric (Part 1) as the contrast point against vasculitis = circumferential.

Practical traps

Stopping at 'stenosis' instead of grading plaque vulnerability.
Trusting a normal lumen — outward (positive) remodeling hides a substantial vulnerable plaque with a normal-looking MRA/CTA.
Reading flow artifact as wall disease when blood is not adequately suppressed.
Mislabeling RCVS as vasculitis on catheter angiography / Calabrese-type criteria and committing a young woman to immunosuppression — the enhancing (vs. quiet) wall and reversibility break the tie.
Treating every Moyamoya pattern as one disease instead of sorting the treatable driver on the wall.
Assuming radiation-related/late-stage Moyamoya will enhance — it may not, even if an early inflammatory window existed.

Teaching pearls

Same lumen, different disease — the wall is where the diagnosis lives.
Atherosclerosis is eccentric; carry that signature into Part 2.
Outward remodeling hides a plaque behind a normal-looking lumen — recurrent symptoms earn a wall study.
Focal eccentric enhancement and intraplaque hemorrhage flag the culprit plaque.
If blood isn't suppressed, you're reading artifact, not wall.
Circumferential and inflamed is vasculitis; eccentric is atherosclerosis; quiet and reversible is RCVS.
RCVS and vasculitis fool the angiogram — the enhancing wall, and reversibility, break the tie.
Don't start steroids on angiography alone — a non-enhancing wall that opens up over weeks is RCVS.
Vessel wall enhancement isn't just diagnosis — it tracks treatment response and targets the biopsy.
Moyamoya is a pattern, not one disease — the wall tells you which driver to treat.

Teaching visuals

Vessel Wall MRI — Concentric vs Eccentric

Source lectures

Intracranial Vessel Wall MRI: Imaging Beyond the Lumen, Part 1
Intracranial Vessel Wall MRI: Imaging Beyond the Lumen, Part 2

Educational material for radiology residents and neuroradiology fellows. Nothing here drives individual patient care, and it contains no patient data.